Citations

Clear

6274 citation(s) found for "To, Andrew".

Radiological Study of the Posterior Septum—Nasal Floor Mucosal Flap
Eltahir, Ahmed , Rezende, Natalia , Luciano, Leonel, Choby, Garret M., Peris‐Celda, Maria , Bowen, Andrew J. , Choby, Garret , Pinheiro‐Neto, Carlos

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | March 4, 2022 | Volume: 83 | Issue: S 01 | Pages: S1-S270

10.1055/s-0042-1743703 Get It

A multicenter retrospective study of polatuzumab vedotin in patients with large B-cell lymphoma after CAR T-cell therapy
Gouni, Sushanth , Crombie, Jennifer L. , Hess, Brian , Watson, Grace, Ayers, Amy , Neelapu, Sattva S. , Khurana, Arushi , Lin, Yi , Strati, Paolo , Rosenthal, Allison C, Neelapu, Sattva S , Khurana, Arushi , Strati, Paolo , Lin, Yi , Rosenthal, Allison , Ip, Andrew , Kamdar, Manali , Feng, Lei , Watson, Grace, Iqbal, Madiha , Merryman, Reid W.

Mayo Clinic

Blood Advances | March 3, 2022 | Volume: 6 | Issue: 9 | Pages: 2757-2762

10.1182/bloodadvances.2021006801 | PMID 35240681 Get It

Abstract Polatuzumab vedotin (PV) is an antibody–drug conjugate targeting CD79b that is approved for patients with relapsed/refractory large B-cell lymphoma (LBCL). Patients who relapse after chimeric antigen receptor (CAR) T-cell therapy were not included in the registration study, and reports of PV use after CAR T cells are limited. This multicenter retrospective analysis included patients with LBCL who relapsed or progressed after CAR T-cell therapy and subsequently received PV with or without rituximab and bendamustine between July 2019 and May 2021. Response to treatment and progression were assessed based on the 2014 Lugano criteria. Fifty-seven patients were included in the study: 18 (32%) patients were primary refractory to CAR T-cell therapy, and 34 (60%) patients received PV-based therapy immediately after CAR T-cell therapy. PV was combined with rituximab in 54 (95%) patients and administered with bendamustine in 35 (61%) patients. A response was achieved in 25 (44%) patients, including complete remission in 8 (14%). No significant association between baseline characteristics and response was observed. After a median follow-up of 47 weeks (95% confidence interval [CI], 40-54), 46 (81%) patients had disease progression or died, and the median progression-free survival was 10 weeks (95% CI, 5-15). On a multivariate analysis, bone marrow involvement (hazard ratio, 5.2; 95% CI, 1.8-15; P = .003) and elevated lactate dehydrogenase levels (hazard ratio, 5.0; 95% CI, 1.4-16; P = .01) were associated with shorter progression-free survival. Studies aimed at better characterizing the intrinsic mechanism of resistance and identifying optimal consolidation strategies for these patients are warranted.
Engaging and Supporting Care Partners of Persons With Dementia in Health-Care Delivery: Results From a National Consensus Conference
Riffin, Catherine , Griffin, Joan M. , Brody, Lilla , Wolff, Jennifer L. , Adelman, Ronald D., Bangerter, Lauren R. , Starks, Steven , Falzarano, Francesca , Villanigro-Santiago, Martha, Veney, Loretta, Falzarano, Francesca , Griffin, Joan M , Pillemer, Karl Andrew , Czaja, Sara J.

Mayo Clinic

Public Policy & Aging Report | March 2, 2022 | Volume: 32 | Issue: 2 | Pages: 58-65

10.1093/ppar/prac004 | PMID 35607366 Get It

A real‐world experience of atrioventricular synchronous pacing with leadless ventricular pacemakers
Kowlgi, Gurukripa N. , Tseng, Andrew S. , Tempel, Nathan D., Henrich, Mark, Venkatachalam, Kalpathi L., Scott, Luis R. , Shen, Win‐Kuang , Deshmukh, Abhishek , Madhavan, Malini , Lee, Hon‐Chi, Asirvatham, Samuel J. , Friedman, Paul A. , Cha, Yong‐Mei , Mulpuru, Siva K. , Henrich, Mark J, Deshmukh, Abhishek J , Tseng, A S , Asirvatham, Samuel J , Kowlgi, Narayan G

Mayo Clinic

Journal of Cardiovascular Electrophysiology | March 2, 2022 | Volume: 33 | Issue: 5 | Pages: 982-993

10.1111/jce.15430 | PMID 35233867 Get It

AbstractAimsThe MicraTM transcatheter pacing system (TPS) (Medtronic) is the only leadless pacemaker that promotes atrioventricular (AV) synchrony via accelerometer‐based atrial sensing. Data regarding the real‐world experience with this novel system are scarce. We sought to characterize patients undergoing MicraTM‐AV implants, describe percentage AV synchrony achieved, and analyze the causes for suboptimal AV synchrony.MethodsIn this retrospective cohort study, electronic medical records from 56 consecutive patients undergoing MicraTM‐AV implants at the Mayo Clinic sites in Minnesota, Florida, and Arizona with a minimum follow‐up of 3 months were reviewed. Demographic data, comorbidities, echocardiographic data, and clinical outcomes were compared among patients with and without atrial synchronous ventricular pacing (AsVP) ≥ 70%.ResultsSixty‐five percent of patients achieved AsVP ≥ 70%. Patients with adequate AsVP had smaller body mass indices, a lower proportion of congestive heart failure, and prior cardiac surgery. Echocardiographic parameters and procedural characteristics were similar across the two groups. Active device troubleshooting was associated with higher AsVP. The likely reasons for low AsVP were small A4‐wave amplitude, high ventricular pacing burden, and inadequate device reprogramming. Importantly, in patients with low AsVP, subjective clinical worsening was not noted during follow‐up.ConclusionWith the increasing popularity of leadless pacemakers, it is paramount for device implanting teams to be familiar with common predictors of AV synchrony and troubleshooting with MicraTM‐AV devices.
Incidentalomas Are Associated With an Increase in Liver Transplantation in Patients With Cirrhosis: A Single-Center Retrospective Study
Cortés, Pedro , Ghoz, Hassan , Malviya, Balkishan, Palmer, William C. , Cortés, Pedro , Stancampiano, Fernando F. , Omer, Mohamed , Bowman, Andrew W.

Mayo Clinic

No container title available | March 1, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-1342298/v1 Get It

Abstract Background: Incidentalomas, defined as incidental findings on imaging, are a growing concern. Our aim was to determine the impact and outcomes of extrahepatic incidentalomas on liver transplantation.Methods: Patients at a large liver transplant center, who had an initial MRI for hepatocellular carcinoma screening between January 2004 and March 2020 were identified. Clinical data were collected retrospectively. Survival analysis, utilizing Kaplan Meier estimates and Cox proportional hazards regression analysis, was utilized to determine factors associated with liver transplantation. Results: 720 patients were included. NASH (24.9%), HCV (22.1%) and alcohol (20.6%) were the most common causes of cirrhosis. 79.7% of patients had an extrahepatic incidentaloma. Older age and having received a liver transplant by the end of the study were associated with an incidentaloma. MELD was not associated with the presence of an incidentaloma. On univariate Cox proportional hazards regression, male gender, history of moderate alcohol use, smoking history, MELD, and incidentalomas were predictors of liver transplantation. On multivariate analysis, only MELD and the presence of an incidentaloma were found to be significant. Discovery of an incidentaloma was associated with a 30% increase in the risk of liver transplantation. Median time to transplantation did not differ based on the presence on an incidentaloma. Patients with cirrhosis from alcohol or HCV had a significantly shorter median time to transplantation than those with NASH. Renal and pancreatic lesions comprised 91% of all incidentalomas.Conclusions: In this single-center retrospective study, extrahepatic incidentalomas were common in patients with cirrhosis. The finding of an incidentaloma was associated with a higher risk of liver transplantation despite a similar median time to transplantation if no incidentaloma was discovered.
Gene expression in lung epithelial cells following interaction with Pneumocystis carinii and its specific life forms yields insights into host gene responses to infection
Kottom, Theodore J. , Carmona, Eva M. , Carmona, Eva M , Kottom, Theodore J , Limper, Andrew H.

Mayo Clinic

Microbiology and Immunology | March 1, 2022 | Volume: 66 | Issue: 5 | Pages: 238-251

10.1111/1348-0421.12972 | PMID 35229348 Get It

Abstract Pneumocystis spp. interacts with epithelial cells in the alveolar spaces of the lung. It is thought that the binding of Pneumocystis to host cell epithelium is needed for life cycle completion and proliferation. The effect of this interaction on lung epithelial cells has previously shown that the trophic form of this organism greatly inhibits p34 cdc2 activity, a serine/threonine kinase required for transition from the G 2 to M phase in the cell cycle. To gain further insight into the host response during Pneumocystis pneumonia infection, we used microarray technology to profile epithelial cell (A549) gene expression patterns following Pneumocystis carinii interaction. Furthermore, we isolated separate populations of cyst and trophic forms of P. carinii , which were then applied to the lung epithelial cells. Differential expression of genes involved in various cellular functions dependent on the specific P. carinii life form in contact with the A549 cell was identified. The reliability of our data was further confirmed by Northern blot analysis on a number of selected upregulated or downregulated transcripts. The transcriptional response to P. carinii was dominated by cytokines, apoptotic, and antiapoptosis‐related genes. These results reveal several previously unknown effects of P. carinii on the lung epithelial cell and provide insight into the complex interactions of host and pathogen.
The Posterior Septal Nasal Floor Mucosal Flap for Cranial Base Reconstruction
Eltahir, Ahmed , Goates, Andrew J. , Rezende, Natalia , Leonel, Luciano, Graepel, Stephen , Xie, Katherine , Gompel, Jamie J. Van , Peris‐Celda, Maria , Bowen, Andrew Jay , Xie, Katherine Z , Van Gompel, Jamie J , Peris-Celda, Maria , Choby, Garret , Pinheiro-Neto, Carlos D , Bowen, Andrew J. , Choby, Garret , Pinheiro‐Neto, Carlos

Mayo Clinic

The Laryngoscope | February 28, 2022 | Volume: 132 | Issue: 8 | Pages: 1561-1568

10.1002/lary.30079 | PMID 35226356 Get It

ObjectiveWhile pedicled intranasal flaps, such as the nasoseptal flap (NSF), successfully reduce postoperative CSF leaks following endoscopic endonasal approaches (EEA) to the skull base, morbidity remains prevalent. This study describes the first cadaveric description and radiographic analysis of the posterior septal nasal floor mucosal flap (PSNF) designed to reduce pedicled nasal flap morbidity. A case series is also detailed.Study DesignCadaveric dissection, radiographic analysis, and case series.MethodsSeven cadaver specimens underwent harvest of the PSNF. PSNF flap dimensions were measured on the thirty deidentified sinus computed tomography (CT) scans. A retrospective case series was performed on the first set of patients who received the PSNF for reconstruction of a sellar base defect. Information concerning complications, symptoms, and the appearance of the flap was recorded from records of the patient's postoperative inpatient stay, 1‐week postop visit, and 1‐month postop visit.ResultsCadaver dissection of the PSNF flap demonstrated good arc rotation along its pedicle with ability to cover both sellar and planum defects. Cadaveric flap measurements and CT‐derived measurements estimated a mean surface area of 16.7 and 18.3 cm2, respectively. 15 patients underwent reconstruction of a sellar or planum defect using the PSNF technique. Only one CSF leak was encountered postoperatively. Minimal crusting of the flap and donor site was seen 1 month postoperatively.ConclusionThe PSNF flap provides a sizeable pedicled region for reconstruction comparable to other pedicled nasal flaps. Our case series demonstrated good postoperative outcomes without reduced donor site morbidity.Level of Evidence4 Laryngoscope, 132:1561–1568, 2022
Survey Study on the Experience, Practice Patterns, and Preferences of the Fellows of the Society of Radiologists in Ultrasound for Evaluation and Management of Gallbladder Polyps Detected With Ultrasound
Middleton, William D., Fung, Christopher, Dahiya, Nirvikar, Szpakowski, Jean-Luc, Corwin, Michael T., Fetzer, David T., Gabriel, Helena, Rodgers, Shuchi K., Tublin, Mitchell E., Walsh, Andrew J., Kamaya, Aya, Fetzer, David T. , Middleton, William D., Fung, Christopher, Dahiya, Nirvikar, Szpakowski, Jean-Luc, Corwin, Michael T., Gabriel, Helena, Rodgers, Shuchi K., TUBLIN, MITCHELL E. , Walsh, Andrew J., Kamaya, Aya

Mayo Clinic

Ultrasound Quarterly | February 28, 2022 | Volume: 38 | Issue: 2 | Pages: 96-102

10.1097/ruq.0000000000000597 | PMID 35221317 Get It

Abstract Gallbladder polyps (GPs) are a common incidental finding on ultrasound; however, important differences in recommended management exist among professional society guidelines. An electronic survey was sent to 189 fellows of the Society of Radiologists in Ultrasound. Main outcomes included preferences and current practice patterns for evaluation, management, and surveillance of GPs as well as personal lifetime experience with gallbladder sonography and GPs. A total of 64 subjects (34%) with experience in gallbladder sonography completed the study. The estimated combined total number of gallbladder scans seen by the responders was 3,071,880. None of fellows had ever seen a pedunculated GP <1 cm detected on ultrasound that was proven to be malignant at the time of detection or during subsequent follow-up. All of the fellows used size as a feature to stratify recommendations. The median size threshold currently used by Society of Radiologists in Ultrasound fellows for recommending ultrasound follow-up was 6 mm, and their preferred threshold was 7 mm. The median size threshold for recommending surgical consultation was 10 mm, and the preferred threshold was 10 mm. Wall thickening and shape were considered important factors by 76% and 67% of respondents, respectively. Society of Radiologists in Ultrasound fellows tend to provide recommendations most similar to the American College of Radiology and Canadian Association of Radiology guidelines for management of GPs. Many would prefer guidelines that result in fewer recommendations for follow-up and surgical consultation. Despite a substantial combined experience, this survey did not uncover any case of a small GP that was malignant.
Contributing Factors to Low Energy Availability in Female Athletes: A Narrative Review of Energy Availability, Training Demands, Nutrition Barriers, Body Image, and Disordered Eating
Jagim, Andrew R. , Fields, Jennifer B. , Magee, Meghan K., Jones, Margaret T. , Jones, Margaret T , Jagim, Andrew R , Kerksick, Chad M.

Mayo Clinic

Nutrients | February 27, 2022 | Volume: 14 | Issue: 5 | Pages: 986

10.3390/nu14050986 | PMID 35267961 Get It

Relative Energy Deficiency in sport is experiencing remarkable popularity of late, particularly among female athletes. This condition is underpinned by low energy availability, which is a byproduct of high energy expenditure, inadequate energy intake, or a combination of the two. Several contributing factors exist that may predispose an athlete to low energy availability, and therefore a holistic and comprehensive assessment may be required to identify the root causes. The focus of the current narrative review is to discuss the primary contributing factors as well as known risk factors for low energy availability among female athletes to help practitioners increase awareness on the topic and identify future areas of focus.
Evaluating the impact of a social medicine course delivered in a local‐global context: A 10‐year multi‐site analysis
Voller, Vanessa , Owilli, Alex Olirus , Yang, Andrew X. , Finnegan, Amy, Westerhaus, Michael, Finnegan, Amy C.

Mayo Clinic

World Medical & Health Policy | February 24, 2022 | Volume: 14 | Issue: 1 | Pages: 54-73

10.1002/wmh3.503 Get It

AbstractAmidst the COVID‐19 pandemic and social uprisings demanding social and racial equity worldwide, there is an increasing demand for health justice training for health workers. However, there are scant evidence‐based assessments of the impact of such courses. Between 2010 and 2020, SocMed—a 501(c)3 non‐profit social justice organization—offered two distinct courses about health equity, the social determinants of health, and social medicine to health workers through the University of Minnesota in Minneapolis, Minnesota and Saint Mary Hospital Lacor in Gulu, Uganda. This study assesses the immediate impact of the SocMed curriculum on participants measured by a pre‐course and post‐course survey. In Minnesota, paired pre‐course and post‐course survey responses (mean n = 69; SD = 23) spanned years 2016–2019, while Uganda paired pre‐course and post‐course survey responses (mean n = 64; SD = 21) spanned years 2012–2013 and 2017–2019. Findings indicate that the course improved participants’ knowledge in all 24 of the topics in the Minnesota course and 42 of 44 topics in the Uganda course (significant at p < 0.05).